Stockreport

Zevra Therapeutics to Participate at Upcoming Investor Conferences

Zevra Therapeutics, Inc.  (ZVRA) 
PDF CELEBRATION, Fla., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics co [Read more]